With a rigorous at-home and in-office assessment schedule, a contraceptive device trial highlights challenges of conducting women’s reproductive health research By: Jessica Hatheway, Program Director, Health Decisions Designing a study that will accurately assess the performance of a contraceptive product requires consideration for numerous factors, including the accuracy of measurement tools, the sexual activity of [...]
About Danielle KroftThis author has not yet filled in any details.
So far Danielle Kroft has created 49 blog entries.
President and Founder of DSP Clinical Research discusses challenges in infertility research and where the industry is headed Until about 15 years ago, research in infertility had been largely stagnate. Standard of care was accepted, and minimal effort was being made to further advance treatment or add new options to the market. As more and [...]
National Women’s Health Week Part 3 With hands-on experience, site staff can provide valuable insights for proactively addressing challenges in clinical trials May 15, 2020 By: Dr. Andrea S. Lukes, MHSc, FACOG, Chief Medical Officer, Health Decisions According to the Tufts Center for the Study of Drug Development (Tufts CSDD), nearly half of all clinical [...]
National Women’s Health Week Part 2 To deliver more meaningful clinical trial results, we need to take the time to gather patient insights May 11, 2020 By: Elizabeth Yarber, Senior Clinical Project Manager, and Kristen Snipes, Director of Clinical Operations, Health Decisions Clinical development is about finding new healthcare solutions that improve lives. This starts [...]
Daré Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Daré’s Novel Pipeline of Women’s Health Programs
Partnership Agreement Intended to Facilitate Advancement of Daré’s Programs in a Capital Efficient Manner; Includes Economic Structures and Dedicated Staff With Clinical Expertise in Women’s Health Products SAN DIEGO AND DURHAM, N.C., May 11, 2020 – Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, and Health Decisions, Inc., a full-service contract research [...]
National Women’s Health Week Part 1 As the FDA reinforces the use of the patient voice in the clinical development process, we need to listen to the women sharing their experiences May 11, 2020 By: John R. Nocero, Senior QA Auditor, Health Decisions In honoring National Women’s Health Week, it’s important to acknowledge the female [...]
Things to consider when establishing R&D priorities as the world addresses the COVID-19 crisis April 7, 2020 There is no doubt that the current public health crisis of COVID-19 is impacting the clinical research world. In the months since it was discovered, dozens of clinical trials aimed at treating, diagnosing and preventing COVID-19 and SARS-CoV-2 [...]
Ongoing efforts to recognize gender differences in clinical research are helping to address women’s health needs March 6, 2020 International Women’s Day has been celebrated on March 8th for more than a century. This year’s theme, #EachforEqual, focuses on the importance of improving gender equality. In honor of International Women’s Day, we are celebrating the [...]
Health Decisions continues the quest for improved women’s health outcomes as the new decade begins January 31, 2020 By Dr. Patrick Phillips, CEO, Health Decisions I’m blessed to have a wonderful mother, wife and three incredible daughters. With so many important women in my life, it seems only natural that I’ve found my way to [...]
HD begins (another) new era of supporting vital reproductive health research By Clint Dart, Vice President, Biostatistics and Programming, Health Decisions September 16, 2019 The contraceptive market has changed substantially since the first birth control pill was approved by the US Food and Drug Administration (FDA) in 1960. Past research has led to the availability [...]